内皮角膜移植术后黄斑囊样水肿的预测因素:2233例单中心回顾
该单中心回顾性研究纳入2233例接受内皮角膜移植(EK)的患者,评估术后黄斑囊样水肿(CMO)的发生率及危险因素。CMO总体发生率为2.82%,DMEK眼(5.56%)高于DSAEK眼(2.36%)(p=0.001)。多因素分析确定年龄>67岁、糖尿病和DMEK为独立危险因素,建议术后第一年密切观察高危患者。
要点
- EK术后CMO总体发生率为2.82%,DMEK眼发生率高于DSAEK眼。
- 年龄>67岁、糖尿病和DMEK是EK术后CMO的独立危险因素。
- CMO平均发生于术后4.27个月,术后第一年需密切观察高危患者。
核心结论
- 年龄>67岁、糖尿病和DMEK是内皮角膜移植术后黄斑囊样水肿的独立危险因素。
- 术后第一年,尤其对存在危险因素的患者,需要密切观察。
研究设计与样本
- 单中心回顾性研究,纳入2005年1月至2018年10月期间接受DSAEK及2014年6月至2018年8月期间接受DMEK的2233例患者,随访至少18个月。
- 采用单变量和多变量分析识别并量化危险因素,并用ROC曲线分析确定连续变量的理想截断点。
主要发现
- CMO总体发生率为2.82%(n=63),DSAEK眼为2.36%,DMEK眼为5.56%(p=0.001)。
- CMO平均发生时间为术后4.27±6.63个月(范围1-34个月)。
- CMO组糖尿病比例高于非CMO组(24.2% vs 9.8%,p<0.001),OR=3.16(95%CI 1.72-5.81,p<0.001)。
- CMO组接受DMEK比例高于非CMO组(28.6% vs 14.1%,p=0.001),OR=2.42(95%CI 1.35-4.33,p=0.003)。
- CMO组年龄更大(70.5±10.0 vs 67.1±14.3岁,p=0.01);以67岁为截断点,年龄>67岁者OR=2.35(95%CI 1.30-4.26,p=0.005)。
关键数值与推荐
- CMO总体发生率2.82%(n=63/2233)。
- DSAEK眼CMO发生率2.36%,DMEK眼5.56%(p=0.001)。
- 糖尿病:OR=3.16(95%CI 1.72-5.81,p<0.001)。
- DMEK:OR=2.42(95%CI 1.35-4.33,p=0.003)。
- 年龄>67岁:OR=2.35(95%CI 1.30-4.26,p=0.005)。
临床怎么用
- 对接受EK的患者,尤其是年龄>67岁、合并糖尿病或接受DMEK者,应在术后第一年密切观察CMO的发生。
- CMO平均发生于术后4.27个月,随访中需关注此时间窗。
局限性
- 单中心回顾性研究设计。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To describe the incidence of postoperative cystoid macular oedema (CMO) after endothelial keratoplasty (EK) and to identify its contributory risk factors. METHODS: 2233 patients undergoing EK at Ospedali Privati Forlì 'Villa Igea', between January 2005 to October 2018 for Descemet stripping automated endothelial keratoplasty (DSAEK) and June 2014 to August 2018 for Descemet membrane endothelial keratoplasty (DMEK) with a minimum follow-up of 18 months were evaluated. Univariate and multivariate analyses were conducted to identify and quantify contributory risk factors. Receiver operating characteristic (ROC) curve analysis were performed to determine ideal cut-off points of continuous variables. RESULTS: CMO was identified in 2.82% (n=63) of the cases. CMO occurred in 2.36% of DSAEK eyes and in 5.56% of DMEK eyes (p=0.001). Average onset of CMO was 4.27±6.63 months (range: 1-34 months) postoperatively. Compared with those who did not develop CMO, a higher proportion of patients in the CMO group had diabetes (24.2% vs 9.8%, p<0.001) (OR=3.16, 95% CI: 1.72 to 5.81, p<0.001), a higher proportion of patients who underwent DMEK rather than DSAEK (28.6% vs 14.1%, p=0.001) (OR=2.42, 95% CI: 1.35 to 4.33, p=0.003) and were older (70.5±10.0 vs 67.1±14.3 years, p=0.01). Using the cut-off of 67 years as identified by ROC curve analysis, subjects aged >67 years (OR=2.35, 95% CI: 1.30 to 4.26, p=0.005) were more likely to develop CMO. There were no other significant differences between the groups. CONCLUSIONS: Older age (>67 years), diabetes mellitus and DMEK have been identified as independent risk factors for postoperative CMO following EK. Close observation is necessary during the first postoperative year after EK, particularly in patients with risk factors.
引用
- Myerscough J, Roberts HW, Yu AC, et al. Factors predictive of cystoid macular oedema following endothelial keratoplasty: a single-centre review of 2233 cases. Br J Ophthalmol. 2021. PMID: 34301611. doi:10.1136/bjophthalmol-2020-318076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。